166 related articles for article (PubMed ID: 9397174)
1. Antirhino/enteroviral vinylacetylene benzimidazoles: a study of their activity and oral plasma levels in mice.
Tebbe MJ; Spitzer WA; Victor F; Miller SC; Lee CC; Sattelberg TR; McKinney E; Tang JC
J Med Chem; 1997 Nov; 40(24):3937-46. PubMed ID: 9397174
[TBL] [Abstract][Full Text] [Related]
2. The effects of antirhino- and enteroviral vinylacetylene benzimidazoles on cytochrome P450 function and hepatic porphyrin levels in mice.
Tebbe MJ; Jensen CB; Spitzer WA; Franklin RB; George MC; Phillips DL
Antiviral Res; 1999 May; 42(1):25-33. PubMed ID: 10333140
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, antiviral activity, and biological properties of vinylacetylene analogs of enviroxime.
Victor F; Brown TJ; Campanale K; Heinz BA; Shipley LA; Su KS; Tang J; Vance LM; Spitzer WA
J Med Chem; 1997 May; 40(10):1511-8. PubMed ID: 9154972
[TBL] [Abstract][Full Text] [Related]
4. An orally bioavailable oxime ether capsid binder with potent activity against human rhinovirus.
Watson KG; Brown RN; Cameron R; Chalmers DK; Hamilton S; Jin B; Krippner GY; Luttick A; McConnell DB; Reece PA; Ryan J; Stanislawski PC; Tucker SP; Wu WY; Barnard DL; Sidwell RW
J Med Chem; 2003 Jul; 46(15):3181-4. PubMed ID: 12852746
[TBL] [Abstract][Full Text] [Related]
5. 2-Amino-3-substituted-6-[(E)-1-phenyl-2-(N-methylcarbamoyl)vinyl]imid azo[1,2-a]pyridines as a novel class of inhibitors of human rhinovirus: stereospecific synthesis and antiviral activity.
Hamdouchi C; de Blas J; del Prado M; Gruber J; Heinz BA; Vance L
J Med Chem; 1999 Jan; 42(1):50-9. PubMed ID: 9888832
[TBL] [Abstract][Full Text] [Related]
6. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 8. Pharmacological optimization of orally bioavailable 2-pyridone-containing peptidomimetics.
Dragovich PS; Prins TJ; Zhou R; Johnson TO; Hua Y; Luu HT; Sakata SK; Brown EL; Maldonado FC; Tuntland T; Lee CA; Fuhrman SA; Zalman LS; Patick AK; Matthews DA; Wu EY; Guo M; Borer BC; Nayyar NK; Moran T; Chen L; Rejto PA; Rose PW; Guzman MC; Dovalsantos EZ; Lee S; McGee K; Mohajeri M; Liese A; Tao J; Kosa MB; Liu B; Batugo MR; Gleeson JP; Wu ZP; Liu J; Meador JW; Ferre RA
J Med Chem; 2003 Oct; 46(21):4572-85. PubMed ID: 14521419
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antiviral activity of C2 analogs of enviroxime: an exploration of the role of critical functionality.
Victor F; Loncharich R; Tang J; Spitzer WA
J Med Chem; 1997 Oct; 40(21):3478-83. PubMed ID: 9341923
[TBL] [Abstract][Full Text] [Related]
8. Anti-enterovirus activity and structure-activity relationship of a series of 2,6-dihalophenyl-substituted 1H,3H-thiazolo[3,4-a]benzimidazoles.
De Palma AM; Heggermont W; Leyssen P; Pürstinger G; Wimmer E; De Clercq E; Rao A; Monforte AM; Chimirri A; Neyts J
Biochem Biophys Res Commun; 2007 Feb; 353(3):628-32. PubMed ID: 17194441
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, antiviral and antitumor activity of 2-substituted-5-amidino-benzimidazoles.
Starcević K; Kralj M; Ester K; Sabol I; Grce M; Pavelić K; Karminski-Zamola G
Bioorg Med Chem; 2007 Jul; 15(13):4419-26. PubMed ID: 17482821
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory properties of 2-substituent-1H-benzimidazole-4-carboxamide derivatives against enteroviruses.
Xue F; Luo X; Ye C; Ye W; Wang Y
Bioorg Med Chem; 2011 Apr; 19(8):2641-9. PubMed ID: 21441033
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antiviral activity against Coxsackie virus B3 of some novel benzimidazole derivatives.
Cheng J; Xie J; Luo X
Bioorg Med Chem Lett; 2005 Jan; 15(2):267-9. PubMed ID: 15603937
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and structure-activity relationships of pyrazolo[3,4-d]pyrimidines: a novel class of potent enterovirus inhibitors.
Chern JH; Shia KS; Hsu TA; Tai CL; Lee CC; Lee YC; Chang CS; Tseng SN; Shih SR
Bioorg Med Chem Lett; 2004 May; 14(10):2519-25. PubMed ID: 15109643
[TBL] [Abstract][Full Text] [Related]
13. Imidazo[1,2-b]pyridazines, novel nucleus with potent and broad spectrum activity against human picornaviruses: design, synthesis, and biological evaluation.
Hamdouchi C; Sanchez-Martinez C; Gruber J; Del Prado M; Lopez J; Rubio A; Heinz BA
J Med Chem; 2003 Sep; 46(20):4333-41. PubMed ID: 13678411
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of a series of 2'-deoxy analogues of the antiviral agent 5,6-dichloro-2-isopropylamino-1-(beta-L-ribofuranosyl)-1H-benzimidazole (1263W94).
Chan JH; Chamberlain SD; Biron KK; Davis MG; Harvey RJ; Selleseth DW; Dornsife RE; Dark EH; Frick LW; Townsend LB; Drach JC; Koszalka GW
Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):101-23. PubMed ID: 10772705
[TBL] [Abstract][Full Text] [Related]
15. 2-substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 2. Effects of aromatic substitution, pharmacological characterization, and bioavailability.
Ornstein PL; Bleisch TJ; Arnold MB; Kennedy JH; Wright RA; Johnson BG; Tizzano JP; Helton DR; Kallman MJ; Schoepp DD; Hérin M
J Med Chem; 1998 Jan; 41(3):358-78. PubMed ID: 9464367
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and antiviral activity of alpha-nucleosides: D- and L-isomers of lyxofuranosyl- and (5-deoxylyxofuranosyl)benzimidazoles.
Migawa MT; Girardet JL; Walker JA; Koszalka GW; Chamberlain SD; Drach JC; Townsend LB
J Med Chem; 1998 Apr; 41(8):1242-51. PubMed ID: 9575044
[TBL] [Abstract][Full Text] [Related]
17. Development of a high-throughput human rhinovirus infectivity cell-based assay for identifying antiviral compounds.
Phillips T; Jenkinson L; McCrae C; Thong B; Unitt J
J Virol Methods; 2011 May; 173(2):182-8. PubMed ID: 21300110
[TBL] [Abstract][Full Text] [Related]
18. 9-Arylpurines as a novel class of enterovirus inhibitors.
Aguado L; Thibaut HJ; Priego EM; Jimeno ML; Camarasa MJ; Neyts J; Pérez-Pérez MJ
J Med Chem; 2010 Jan; 53(1):316-24. PubMed ID: 19924996
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and activity of piperazine-containing antirhinoviral agents and crystal structure of SDZ 880-061 bound to human rhinovirus 14.
Oren DA; Zhang A; Nesvadba H; Rosenwirth B; Arnold E
J Mol Biol; 1996 May; 259(1):120-34. PubMed ID: 8648640
[TBL] [Abstract][Full Text] [Related]
20. Application of oral bioavailability surrogates in the design of orally active inhibitors of rhinovirus replication.
Stratford RE; Clay MP; Heinz BA; Kuhfeld MT; Osborne SJ; Phillips DL; Sweetana SA; Tebbe MJ; Vasudevan V; Zornes LL; Lindstrom TD
J Pharm Sci; 1999 Aug; 88(8):747-53. PubMed ID: 10430536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
